Literature DB >> 33494763

Hsa_circ_0010235 functions as an oncogenic drive in non-small cell lung cancer by modulating miR-433-3p/TIPRL axis.

Furui Zhang1, Ruirui Cheng1, Ping Li2, Chunya Lu1, Guojun Zhang1.   

Abstract

BACKGROUND: Non-small cell lung cancer (NSCLC) is a threat to human health. Circular RNAs (circRNAs) have been proved to function in NSCLC development. In this study, the role of circRNA hsa_circ_0010235 in NSCLC progression and the possible molecular mechanism were explored.
METHODS: Expression of hsa_circ_0010235, miRNA (miR)-433-3p and TOR signaling pathway regulator-like (TIPRL) was examined by quantitative real-time PCR (qRT-PCR). Cell viability and clonogenicity were detected by cell counting kit-8 (CCK-8) assay and colony formation assay, respectively. Flow cytometry was performed to monitor cell apoptosis and cell cycle distribution. Western blot assay was employed to evaluate the protein levels of TIPRL, light chain 3 (LC3)-II/I and p62. Cell metastasis was assessed by Transwell and wound healing assays. The targeted relationship between miR-433-3p and hsa_circ_0010235 or TIPRL was confirmed by dual-luciferase reporter and RNA immunoprecipitation (RIP) assays. Furthermore, the role of hsa_circ_0010235 in vivo was investigated by xenograft assay.
RESULTS: Hsa_circ_0010235 and TIPRL were highly expressed in NSCLC tissues and cells, while miR-433-3p was downregulated. Depletion of hsa_circ_0010235 or gain of miR-433-3p repressed proliferation and autophagy but promoted apoptosis in NSCLC cells. Hsa_circ_0010235 sponged miR-433-3p to upregulate TIPRL expression, so as to affect NSCLC development. Hsa_circ_0010235 knockdown also blocked tumor growth in vivo.
CONCLUSION: Hsa_circ_0010235 knockdown suppressed NSCLC progression by regulating miR-433-3p/TIPRL axis, affording a novel mechanism of NSCLC progression.

Entities:  

Keywords:  Hsa_circ_0010235; NSCLC; TIPRL; Tumorigenesis; miR-433-3p

Year:  2021        PMID: 33494763      PMCID: PMC7836483          DOI: 10.1186/s12935-021-01764-8

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  36 in total

Review 1.  Mechanisms of regulation of mature miRNAs.

Authors:  Benjamin P Towler; Christopher I Jones; Sarah F Newbury
Journal:  Biochem Soc Trans       Date:  2015-12       Impact factor: 5.407

2.  miR-433 suppresses tumor progression via Smad2 in non-small cell lung cancer.

Authors:  Jianing Li; Meng Chen; Baiquan Yu
Journal:  Pathol Res Pract       Date:  2019-08-12       Impact factor: 3.250

Review 3.  Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer.

Authors:  Chunyan Li; Lin Zhang; Guangping Meng; Qi Wang; Xuejiao Lv; Jie Zhang; Junyao Li
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-19       Impact factor: 4.553

4.  Circular RNAs are a large class of animal RNAs with regulatory potency.

Authors:  Sebastian Memczak; Marvin Jens; Antigoni Elefsinioti; Francesca Torti; Janna Krueger; Agnieszka Rybak; Luisa Maier; Sebastian D Mackowiak; Lea H Gregersen; Mathias Munschauer; Alexander Loewer; Ulrike Ziebold; Markus Landthaler; Christine Kocks; Ferdinand le Noble; Nikolaus Rajewsky
Journal:  Nature       Date:  2013-02-27       Impact factor: 49.962

5.  MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein.

Authors:  Zhihong Yang; Hiroyuki Tsuchiya; Yuxia Zhang; M Elizabeth Hartnett; Li Wang
Journal:  J Biol Chem       Date:  2013-08-26       Impact factor: 5.157

Review 6.  A brief review on the mechanisms of miRNA regulation.

Authors:  Yimei Cai; Xiaomin Yu; Songnian Hu; Jun Yu
Journal:  Genomics Proteomics Bioinformatics       Date:  2009-12       Impact factor: 7.691

Review 7.  Circular RNAs: Regulators of Cancer-Related Signaling Pathways and Potential Diagnostic Biomarkers for Human Cancers.

Authors:  Zuozhang Yang; Lin Xie; Lei Han; Xin Qu; Yihao Yang; Ya Zhang; Zewei He; Yu Wang; Jing Li
Journal:  Theranostics       Date:  2017-07-22       Impact factor: 11.556

Review 8.  MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential.

Authors:  Hannah Petrek; Ai-Ming Yu
Journal:  Pharmacol Res Perspect       Date:  2019-12

9.  miR-433 inhibits breast cancer cell growth via the MAPK signaling pathway by targeting Rap1a.

Authors:  Tao Zhang; Kangfeng Jiang; Xinying Zhu; Gan Zhao; Haichong Wu; Ganzhen Deng; Changwei Qiu
Journal:  Int J Biol Sci       Date:  2018-05-15       Impact factor: 6.580

10.  TIPRL potentiates survival of lung cancer by inducing autophagy through the eIF2α-ATF4 pathway.

Authors:  Su-Jin Jeon; Jun-Ho Ahn; Debasish Halder; Hyun-Soo Cho; Jung-Hwa Lim; Soo Young Jun; Jeong-Ju Lee; Ji-Yong Yoon; Min-Hyuk Choi; Cho-Rok Jung; Jin-Man Kim; Nam-Soon Kim
Journal:  Cell Death Dis       Date:  2019-12-20       Impact factor: 8.469

View more
  9 in total

1.  CircRNA circ_0008037 facilitates tumor growth and the Warburg effect via upregulating NUCKS1 by binding to miR-433-3p in non-small cell lung cancer.

Authors:  Jia Yu; Haining Zhang; Chunsheng Zhao; Guanghui Li; Yingying Zhang; Yang Sun
Journal:  Thorac Cancer       Date:  2021-12-01       Impact factor: 3.500

Review 2.  Circular RNA: A promising new star for the diagnosis and treatment of colorectal cancer.

Authors:  Shunhao Zhang; Jing Sun; Minqi Gu; Guihua Wang; Xudong Wang
Journal:  Cancer Med       Date:  2021-11-18       Impact factor: 4.452

3.  Circ_0010235 facilitates lung cancer development and immune escape by regulating miR-636/PDL1 axis.

Authors:  Jixing Zhao; Wu Yan; Wencong Huang; Yongsheng Li
Journal:  Thorac Cancer       Date:  2022-02-15       Impact factor: 3.500

Review 4.  Regulation of apoptosis, autophagy and ferroptosis by non-coding RNAs in metastatic non-small cell lung cancer (Review).

Authors:  Lei Xu; Xin Huang; Yan Lou; Wei Xie; Hangyu Zhao
Journal:  Exp Ther Med       Date:  2022-03-28       Impact factor: 2.447

Review 5.  MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy.

Authors:  Janusz Matuszyk
Journal:  Mol Med       Date:  2022-08-03       Impact factor: 6.376

6.  Circ_0010235 Regulates HOXA10 Expression to Promote Malignant Phenotypes and Radioresistance in Non-small Cell Lung Cancer Cells Via Decoying miR-588.

Authors:  Hongyan Zhu; Wenshu Yang; Qingping Cheng; Shuai Yang
Journal:  Balkan Med J       Date:  2022-07-22       Impact factor: 3.570

Review 7.  Circular RNA-regulated autophagy is involved in cancer progression.

Authors:  Xuejian Zhou; Juntao Lin; Feifan Wang; Xianwu Chen; Yan Zhang; Zhenghui Hu; Xiaodong Jin
Journal:  Front Cell Dev Biol       Date:  2022-09-14

Review 8.  The role of MiRNA-433 in malignant tumors of digestive tract as tumor suppressor.

Authors:  Jie Tang; Jiawei Chen; Yongqiang Wang; Shaobo Zhou
Journal:  Cancer Rep (Hoboken)       Date:  2022-08-17

Review 9.  Research progress on the relationship between the TOR signaling pathway regulator, epigenetics, and tumor development.

Authors:  Jiaen Sun; Minglei Yang; Weidi Zhao; Fajiu Wang; Liangwei Yang; Chuntao Tan; Tianjun Hu; Huangkai Zhu; Guofang Zhao
Journal:  Front Genet       Date:  2022-09-23       Impact factor: 4.772

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.